Hairy cell leukemia surgery: Difference between revisions

	Hairy cell leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hairy cell leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hairy cell leukemia surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hairy cell leukemia surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hairy cell leukemia surgery
CDC on Hairy cell leukemia surgery
Hairy cell leukemia surgery in the news
Blogs on Hairy cell leukemia surgery
Directions to Hospitals Treating Hairy cell leukemia
Risk calculators and risk factors for Hairy cell leukemia surgery

Revision as of 02:30, 30 October 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] {AE}}Haytham Allaham, M.D. [2]

The predominant therapy for hairy cell leukemia is chemotherapy. Surgical management, such as splenectomy, may be required in certain cases.

The predominant therapy for hairy cell leukemia is chemotherapy. Surgical management, such as splenectomy, may be required in certain cases.

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Hairy cell leukemia}}
-{{CMG}}
+{{CMG}} {AE}}{{HL}}
 ==Overview==
+The predominant therapy for hairy cell leukemia is chemotherapy. Surgical management, such as [[splenectomy]], may be required in certain cases.
 ==Surgery==
+The predominant therapy for hairy cell leukemia is chemotherapy. Surgical management, such as [[splenectomy]], may be required in certain cases.
-===Splenectomy===
-[[Splenectomy]] can produce long-term remissions in patients whose spleens seem to be heavily involved, but its success rate is noticeably lower than cladribine or pentostatin.  Splenectomies are also performed for patients whose persistently enlarged spleens cause significant discomfort or in patients whose persistently low platelet counts suggest [[Idiopathic thrombocytopenic purpura]].
-===Bone marrow transplant===
-[[Bone marrow transplant]]s are usually shunned in this highly treatable disease because of the inherent risks in the procedure.  They may be considered for refractory cases in younger, otherwise healthy individuals.  "Mini-transplants" are possible.
 ==References==
-{{reflist|2}}
+{{reflist|1}}
 [[Category:Disease]]